Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-09
DOI
10.1038/s41598-017-08842-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies
- (2017) Rohit Shukla et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase
- (2017) Rohit Shukla et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility
- (2017) Harish Shukla et al. Scientific Reports
- High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania
- (2016) Rajan Kumar Pandey et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase
- (2016) Rajan Kumar Pandey et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation
- (2016) Rajan Kumar Pandey et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase
- (2016) Rajan Kumar Pandey et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- Developing imidazole analogues as potential inhibitor forLeishmania donovanitrypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach
- (2015) Rajan Kumar Pandey et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?
- (2015) Meghan Perry et al. LANCET
- Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis
- (2015) Rajeev Nagill et al. Asian Pacific Journal of Tropical Medicine
- Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice
- (2015) Anita Masic et al. PLoS One
- In vitro Susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis
- (2013) Vijay Kumar Prajapati et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins
- (2013) Douglas B Craig et al. BMC BIOINFORMATICS
- Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani
- (2013) Sudipta Hazra et al. EXPERIMENTAL PARASITOLOGY
- Case study for a vaccine against leishmaniasis
- (2013) Jorge Alvar et al. VACCINE
- Visceral leishmaniasis: immunology and prospects for a vaccine
- (2011) P.M. Kaye et al. CLINICAL MICROBIOLOGY AND INFECTION
- Vaccines and global health
- (2011) B. Greenwood et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen
- (2010) R. MAURYA et al. PARASITE IMMUNOLOGY
- Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines
- (2009) Lukasz Kedzierski et al. CURRENT MEDICINAL CHEMISTRY
- ElliPro: a new structure-based tool for the prediction of antibody epitopes
- (2008) Julia Ponomarenko et al. BMC BIOINFORMATICS
- Predicting linear B‐cell epitopes using string kernels
- (2008) Yasser EL‐Manzalawy et al. JOURNAL OF MOLECULAR RECOGNITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now